Drug intelligence / Profile preview

creatine monohydrate + conjugated linoleic acid

Development stage
Unknown
Lead developer
McMaster University
Modality
Small Molecules
Administration
Oral
01

Overview

This combination nutritional supplement intervention consists of **creatine monohydrate** and **conjugated linoleic acid (CLA)**. It was evaluated in a randomized, double-blind, placebo-controlled clinical trial (NCT00473902) as an adjunct to resistance exercise training for the treatment of **sarcopenia** in older adults. Creatine monohydrate acts by increasing intramuscular phosphocreatine stores, which facilitates the rapid regeneration of ATP during high-intensity muscle contraction, thereby enhancing strength and lean mass gains. Conjugated linoleic acid is a group of fatty acid isomers that may improve body composition by reducing fat mass and potentially increasing fat-free mass through the modulation of lipid metabolism and inflammatory pathways. The study, led by researchers at **McMaster University** and **Hamilton Health Sciences Corporation**, demonstrated that the combination could enhance the beneficial effects of resistance training on strength and body composition in individuals over 65 years of age.

Other names
creatine + CLACrM + CLA
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on creatine monohydrate + conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on creatine monohydrate + conjugated linoleic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call